Table 6 Assessment of the potential cost of medication errors
From: Chemotherapeutic errors in hospitalised cancer patients: attributable damage and extra costs
Haematology | Oncology1 | Pneumology | |||||
|---|---|---|---|---|---|---|---|
a | b | c | d | e | f | Total2 | |
Cost linked to new potential hospitalisation (€ 2008) | 7, 908.5 | 5, 354.2 | 3, 614.3 | 844.9 | 0 | 0 | 8, 861 |
Cost linked to potential prolongation of hospitalisation (€ 2008) | 26, 720.9 | 29, 213.8 | 24, 039.5 | 21, 232.3 | 13, 259.6 | 6, 309.1 | 60, 387.6 |
Cost linked to drugs paid for in addition to the diagnosis-related groups (€ 2008) | 8, 313.9 | 8, 383.9 | 12, 378.8 | 12, 378.8 | 2, 930.9 | 2, 930.9 | 23, 658.6 |
Total (€ 2008) | 42, 943.3 | 42, 951.9 | 40, 032.6 | 34, 456 | 16, 190.5 | 9, 240 | 92, 907.2 |